 |
Technical Support
(877) SEPAX-US, press 3  TechSupport@sepax-tech.com |
  |
| By Separation Mode | By Brand | By Sample Based Application | |
|
Size Exclusion Ion Exchange Hydrophobic Interaction Ion Exclusion Sub-2 UHPLC Purification Reversed Phase Mixed-mode Phase HILIC View All |
SEC-MALS Unix / Unix-C Zenix / Zenix-C SRT / SRT-C SRT-10 / SRT-10C Proteomix HIC / IEX Antibodix Carbomix Proteomix RP View All |
ADC Antibody Biosimilar Carbohydrate Cell Lysate DNA/RNA Fusion Protein Glycan Glycoprotein Heparin |
Insulin Membrane Protein Organic Acid PEG/PEGylated Protein Peptide Polymer Protein Vaccine/VLP Others |
How May We Help You?
How May We Help You?
How May We Help You?
Your question has been submitted.
We will respond back to you shortly.
We will respond back to you shortly.
How May We Help You?
Please fill out all required fields.
Samples
Sample: ProteinProtein Recommended products
Size Exclusion:
Unix
Zenix
Zenix-C
SRT
SRT-C
Preparative SEC
Ion Exchange: Proteomix Antibodix Reversed phase: Proteomix RP Bio-C4
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Application Note
Featured Application Notes
All Application Notes
| App ID | Title |
| LR2024081527 | Literature Reference: Universal Paramyxovirus Vaccine Design by Stabilizing Regions Involved in Structural Transformation of the Fusion Protein | Size ExclusionUnix-C SEC-300Paramyxovirus Vaccine, RV3 Fusion (F) protein, SEHPLC1
| UNIXP1002 | Unix 1.8 µm UHPLC SEC for Fast Ultra High Resolution Biomolecule Separation | Size ExclusionUnixResolution@Aggregates@Fast Assay@Column Stability@Lot to Lot@Particle Size Impact@LoadingHPLC@UHPLC1
| SQ1003 | Membrane Protein Separation on Size Exclusion | Size Exclusion@Size Exclusion@Size Exclusion@Size Exclusion@Size Exclusion@Size Exclusion@Size Exclusion@Size Exclusion@Size Exclusion@Size ExclusionSRT@SRT-C@NanofilmPore Size Selection@Packing Chemistry@Resolution@AggregatesHPLC1
| SP1021 | Complex Protein Sample Mixtures Analysis on Sepax Columns | Size Exclusion@Size Exclusion@Size Exclusion@Size Exclusion@Size Exclusion@Ion Exchange@Ion Exchange@Ion Exchange@Reversed Phase@Reversed PhaseSRT@Zenix@Proteomix@Proteomix RPResolution@Pore Size Selection@LoadingHPLC1
| EP1004 | Fusion Protein Separation on SEC and SAX | Size Exclusion@Size Exclusion@Size Exclusion@Ion ExchangeZenix-C@Zenix@ProteomixMethod Optimization@Packing Chemistry@Aggregates@Orthogonal Method@ResolutionHPLC1
| PG1002 | Pegylated Protein Separation on SEC and SAX | Size Exclusion@Ion ExchangeProteomix@Zenix@Zenix-CAggregates@Resolution@Orthogonal Method@Pore Size Selection@Packing ChemistryHPLC1
| LR2025011554 | Literature Reference: Structure-guided discovery of viral proteins that inhibit host immunity | Size ExclusionSRTSEC, ProteinHPLC1
| LR20220261 | Literature Reference: Characterization of Fc-fusion protein aggregates derived from extracellular domain disulfide bond rearrangements | SECSRTAggregates, Method Optimization, Optimization, SEC-MALS, Oligonucleotide Separation, Fusion Protein SeparationHPLC1
| PP1028 | Literature Reference: Characterization of Human Serum Albumin Isoforms by Ion Exchange Chromatography Coupled On-line To Native Mass Spectrometry | IEXProteomixLC/MSLC/MS@HPLC1
| PP1027 | Literature Reference: Proteomix SAX Separation of EPO Charge Isomers | IEXProteomixLC/MSLC/MS@HPLC1
| EG1001 | Sepax PEGylated Lysozyme- SEC, RP, IEX and MM | Size Exclusion@Reversed Phase@Ion Exchange@MMZenix@Proteomix@Bio-C4@Bio-C18PEGylated LysozymeHPLC1
| s41596-020-0304-x | Literature Reference: Generation of synthetic nanobodies against delicate proteins | Size ExclusionSRT-10CPurificationFPLC1
| PP1026 | Fc Fusion Protein Separation on Sepax Proteomix SAX Columns | Ion ExchangeProteomixFusion Protein SeparationHPLC1
| PP1023 | Human Serum on Zenix-C 300 and Proteomix SAX-NP3 | Size Exclusion@Ion ExchangeZenix-C@ProteomixHuman SerumHPLC1
| PP1004 | Separation of Proteins on Proteomix WCX - Effect of Particle Size | Ion ExchangeProteomix@Proteomix WCXSeparation of ProteinsHPLC1
| NQ1002 | BSA (66 kD) in 0.1% LDAO | Size ExclusionSRT@NanofilmBSAHPLC1
| EP1008 | Eylea-Aflibercept | Size ExclusionZenix-CAggregates@Method Optimization@ResolutionHPLC2
| WP1001 | Fusion Protein Enbrel Separation on Unix-C UHPLC SEC Column | Size ExclusionUnix-CResolution@Aggregates@Competition Comparison@Column Stability@Lot to Lot@Particle Size Impact@LoadingUHPLC2
| HICP1001 | HICP1001 - Fusion protein Analysis on Proteomix® HICBu-NP5 ( 4603 ) | Hydrophobic InteractionProteomix@Proteomix HICResolution@Orthogonal MethodHPLC2
| SP1013 | Small Protein Purification on SRT-10 100Å SEC Prep Size Column | Size ExclusionSRT-10Pore Size Selection@Resolution@Fast Assay@PurificationFPLC2
| SP1012 | SEC-300 Overlay with Different Particle Sizes -QC standard overlays with 3, 5, 10 mm SEC-300, 7.8 x 300 mm | Size ExclusionSRT@Zenix@SRT-10Resolution@Method OptimizationHPLC2
| SP1011 | Protein on SRT SEC-300 5 µm vs 10 µm-Particle Size Impact | Size Exclusion@Size ExclusionSRT@SRT-10Resolution@Particle Size Impact@Fast AssayHPLC@FPLC2
| SG1001 | 39 kD PEGylated Protein Analysis on SRT SEC-150 and SEC-300 | Size Exclusion@Size ExclusionSRTPore Size Selection@Resolution@AggregatesHPLC2
| EP1007 | Protein Standards on Zenix-C and SRT-C SEC-300 | Size Exclusion@Size ExclusionZenix-C@SRT-CParticle Size Impact HPLC2
| BH1001 | Analysis of Recombinant Human Growth Hormone on Bio-C4 | Reversed PhaseBio-C4Resolution@Packing Chemistry@Pore Size Selection HPLC@LCMS2
| PP1025 | Proteomix RP-1000 Lot to Lot Consistency Study | Reversed PhaseProteomix RPLot to Lot@Volatile BufferHPLC/LCMS2
| PP1024 | Protein Separation on Proteomix SCX - Volatile buffer | Ion ExchangeProteomixVolatile Buffer@Resolution HPLC/LCMS2
| ZP1018 | Life Time Test of Zenix 300 with High Salt at pH 8.5 | Size ExclusionZenixColumn StabilityHPLC2
| SP1019 | Preparative SEC Protein Separation by SRT-10 | Size ExclusionSRT-10Resolution@Loading@Fast AssayHPLC@FPLC2
| RQ1005 | BSA in 0.02% TDM Analysis-SEC Analysis | Size ExclusionSRT-CPacking Chemistry@AggregatesHPLC2
| PP1021 | HSA Fusion Protein Analysis on Proteomix SAX | Ion ExchangeProteomixResolutionHPLC2
| PG1001 | Pegylated BSA Separation on SEC and SAX | Size Exclusion@Ion ExchangeProteomix@Zenix@SRTAggregates@Resolution@Loading@Orthogonal Method@Pore Size SelectionHPLC2
| EP1003 | HSA Fusion Protein Separation on Zenix and Zenix-C 300 | Size ExclusionZenix-C@ZenixMethod Optimization@Packing Chemistry@AggregatesHPLC3
| EP1002 | DTT and EDTA Effect on SEC Protein Separation | Size ExclusionZenix-CMethod OptimizationHPLC3
| EP1001 | Fusion Protein Separation on Zenix and Zenix-C 300 | Size ExclusionZenix-C@ZenixAggregates@Method Optimization@Packing ChemistryHPLC3
| EP1006 | Human Serum Separation on Zenix-C and SAX | Ion Exchange@Size ExclusionProteomix@Zenix-CResolution@Orthogonal MethodHPLC3
| EP1005 | 2.1 mm ID SEC for Protein Separation | Size ExclusionZenix-C Volatile Buffer@Method OptimizationHPLC@LCMS@NanoLC3
| ZP1007 | Fast Assay Application on Zenix-300 | Size ExclusionZenixFast AssayHPLC3
| ZP1020 | rhEPO (CHO cell) Separation on Zenix SEC-150 | Size ExclusionZenixResolutionHPLC3
| QP1001 | Protein Separation on Proteomix RP-1000 Reversed Phase Column | Reversed PhaseProteomix RPVolatile BufferHPLC@LCMS3
| ZP1019 | Protein Separation on Zenix SEC-300 with HPLC and FPLC system | Size ExclusionZenixResolutionFPLC@HPLC3
| SQ1002 | Ferritin in 0.1% UDM-SEC Analysis | Size ExclusionNanofilm@SRT-C@SRTPacking ChemistryHPLC3
| RQ1003 | BSA in 0.1% LDAO-SEC Analysis | Size ExclusionNanofilm@SRT-C@SRTPacking Chemistry@Pore Size SelectionHPLC3
| EE1001 | mPEG-peptide on Zenix and Zenix-C SEC | Size ExclusionZenix-C@ZenixPacking ChemistryHPLC3
| RQ1002 | Membrane protein Aqpz in Octyl glucoside Detergent-SEC Analysis | Size ExclusionNanofilm@Zenix@SRT-CPacking ChemistryHPLC3
| NQ1001 | Photosynthetic Reaction Center in 0.1% LDAO Detergent-SEC Analysis | Size ExclusionNanofilm@SRT@SRT-CPacking ChemistryHPLC3
| PP1019 | Lifetime Test on 2 µm Proteomix SCX | Ion ExchangeProteomixColumn StabilityHPLC@UHPLC3
| PP1018 | Lot to Lot Consistency for Sub 2 µm Proteomix WCX | Ion ExchangeProteomixLot to Lot@Fast AssayHPLC@UHPLC3
| PP1017 | Lot to Lot Consistency for Sub 2 µm Proteomix SCX | Ion ExchangeProteomixLot to Lot@Fast AssayHPLC@UHPLC4
| PP1016 | Particle Size Impact for Proteomix WCX | Ion ExchangeProteomixParticle Size ImpactHPLC4
| PP1015 | Particle Size Impact for Proteomix SCX | Ion ExchangeProteomixParticle Size ImpactHPLC4
| PP1014 | Protein Mixture on Sub 2 µm Proteomix WCX | Ion ExchangeProteomixResolution@Fast AssayHPLC@UHPLC4
| PP1013 | Protein Mixture on Sub 2 µm Proteomix SCX | Ion ExchangeProteomixResolution@Fast AssayHPLC@UHPLC4
| AP1005 | Lifetime Test on Sub 2 µm Antibodix | Ion ExchangeAntibodixColumn StabilityHPLC@UHPLC4
| AP1004 | Protein Mixture on Sub 2 µm Antibodix | Ion ExchangeAntibodixResolution@Fast AssayHPLC@UHPLC4
| ZE1009 | Analysis of Exenatide and Pegylated Exenatide on Zenix and Zenix-C SEC | Size ExclusionZenix@Zenix-CPacking Chemistry@Aggregates@Volatile Buffer@ResolutionHPLC@LCMS4
| PP1010 | Intact Glycoprotein Isoforms Separation on Proteomix SAX | Ion Exchange@Size ExclusionProteomix@ZenixResolution@Aggregates@Charge Variants@Method Optimization@Loading@Orthogonal MethodHPLC@LCMS4
| PP1009 | Analysis of Glycoproteins on Proteomix SAX | Ion ExchangeProteomixResolution@Charge VariantsHPLC4
| SV1005 | LDL, HDL and VLDL on SRT-1000 | Size ExclusionSRTResolution@Pore Size SelectionHPLC4
| ZP1011 | Lysozyme Elution Profiles on Zenix | Size ExclusionZenixMethod OptimizationHPLC4
| ZJ1001 | Light Scattering Detection of BSA on Zenix SEC-300 | Size ExclusionZenixResolutionHPLC4
| ZZ1004 | SEC Separation of Protein Mixtures on SRT and TSKgel | Size ExclusionSRTCompetition Comparison@ResolutionHPLC4
| ZL1001 | PEG Separation on Zenix SEC | Size ExclusionZenixResolutionHPLC4
| ZP1009 | Analysis of Fc Fusion Protein on Zenix vs. SRT | Size ExclusionZenix@SRTParticle Size ImpactHPLC4
| ZP1008 | Fast Separation of Horse Serum by Zenix | Size ExclusionZenixFast AssayHPLC5
| ZP1005 | Separation of Protein Mixture by Zenix Phases | Size ExclusionZenixPore Size SelectionHPLC5
| ZP1004 | Separation of Bio-Rad Protein Mixture by Zenix | Size ExclusionZenixPore Size SelectionHPLC5
| ZP1003 | MW Calibration Curve on Zenix Phases | Size ExclusionZenixPore Size SelectionHPLC5
| ZP1002 | Improved Resolution on 3 µm SEC | Size ExclusionSRT@ZenixParticle Size ImpactHPLC5
| ZP1001 | 3 & 5 µm SEC on Separation Efficiency | Size ExclusionZenix@SRTParticle Size ImpactHPLC5
| ZG1001 | PEGylated Protein Analysis on Zenix | Size ExclusionZenixResolution@AggregatesHPLC5
| ZE1001 | Separation of Proteins and Peptide on Zenix Mixture | Size ExclusionZenixPore Size SelectionHPLC5
| SP1008 | EPO Analysis on SRT SEC-300 | Size ExclusionSRTResolutionHPLC5
| SP1006 | Protein Separation in Organic Buffer on SRT | Size ExclusionSRTVolatile BufferHPLC@LCMS5
| SP1005 | From Analytical to Semi-Prep Separation on SRT-10 | Size ExclusionSRT-10ResolutionHPLC@FPLC5
| SP1004 | The Column Length Impact on Separation Efficiency | Size ExclusionSRT-10ResolutionHPLC@FPLC5
| SP1003 | Protein Separation Profiles on SRT-10 Phase | Size ExclusionSRT-10Pore Size SelectionHPLC@FPLC5
| SP1002 | Separation of Human Recombinant Protein on SRT-1000 | Size ExclusionSRTResolutionHPLC5
| SP1001 | Separation of Thyroglobulin and Aggregates on SRT-1000 | Size ExclusionSRTAggregatesHPLC5
| SL1003 | PEG Analysis on SRT-150 and SRT-300 | Size ExclusionSRTPore Size SelectionHPLC5
| RP1003 | SRT-C Stability Test for Protein | Size ExclusionSRT-CColumn StabilityHPLC6
| RP1001 | Protein Loading Capacity Study on SRT-C 300 | Size ExclusionSRT-CLoadingHPLC6
| PP1008 | High Resolution of Proteins with different pI on Proteomix SCX | Ion ExchangeProteomixResolutionHPLC6
| PP1007 | Loading Capacity of RNaseA on Proteomix SCX | Ion ExchangeProteomixLoadingHPLC6
| PP1006 | SAX Analysis of Horse Serum on Proteomix vs. Porous | Ion ExchangeProteomixCompetition Comparison@Pore Size SelectionHPLC6
| PP1005 | Separation of Ovalbumin and BSA on Proteomix SAX | Ion ExchangeProteomixResolutionHPLC6
| PC1001 | Separation of Carbohydrates in Volatile Buffer on Proteomix SAX | Ion ExchangeProteomixVolatile BufferHPLC@LCMS6
| AP1003 | Particle Size Impact on Protein Separation on Antibodix | Ion ExchangeAntibodixParticle Size ImpactHPLC6
| AP1002 | WCX Separation of Proteins on Antibodix Sub 2 um | Ion ExchangeAntibodixResolution@Fast AssayHPLC@UHPLC6
| SP1022 | Fast Protein Purification with 5 cm ID Large Preparative Size SRT-10 SEC Column | Size ExclusionSRT-10Purification@Particle Size Impact@Fast Assay@Loading@ResolutionHPLC6
| NQ1004 | Membrane protein Aqpz separation in Octyl glucoside | Size ExclusionNanofilm@Zenix@SRTAqpz separationHPLC6
| NQ1003 | Ferritin (440 kD) in 0.1% UDM | Size ExclusionSRT@NanofilmFerritinFPLC6
| LR2024021488 | Literature Reference: Structural Insights Into CXCR4 Modulation and Oligomerization | Size ExclusionZenix-CSize Exclusion, Membrane protein separation, GPCRHPLC6
| EG1000 | PEGylated Protein Separation- SEC and RP | Size Exclusion@Reversed PhaseZenix@Proteomix@Bio-C4@Bio-C18PEGylated Protein SeparationHPLC6